Artiva Biotherapeutics In... (ARTV)
NASDAQ: ARTV
· Real-Time Price · USD
2.94
0.19 (6.91%)
At close: Aug 18, 2025, 10:40 AM
Artiva Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Net Income | -21.25M | -20.31M | -16.09M | -17.47M | -17.84M | -13.96M | -12M | 11.28M | -11.28M | -16.72M |
Depreciation & Amortization | -591K | 628K | 614K | 627K | 603K | 587K | 594K | 556K | 538K | 578K |
Stock-Based Compensation | 1.55M | 2.05M | 2.18M | 1.91M | 1.48M | 1.41M | 1.39M | 1.37M | 2.46M | 1.83M |
Other Working Capital | 1.44M | -1.44M | -784K | 1.54M | 685K | 45K | -881K | -24.8M | -1.78M | 388K |
Other Non-Cash Items | -4.17M | -723K | -1.04M | 318K | 2.08M | n/a | 424K | -159K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.49M | -1.49M | -311K | 3.01M | -7K | -3.02M | -1.09M | -23.8M | -3.46M | 64K |
Operating Cash Flow | -22.98M | -19.84M | -14.65M | -11.61M | -13.69M | -15.09M | -10.68M | -10.75M | -11.76M | -14.24M |
Capital Expenditures | -1.05M | -511K | -64K | -96K | -464K | -18K | -636K | -179K | -581K | -1.86M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -6.07M | -18.52M | -14.85M | -142.93M | -12.19M | -6.2M | -14.83M | -12.31M | -22.37M | n/a |
Sales Maturities Of Investments | 28.25M | 29M | 13.95M | 12.4M | 14M | 16M | 12.8M | 12M | 2M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 21.12M | 9.97M | -966K | -130.63M | 1.35M | 9.78M | -2.67M | -493K | -20.95M | -1.86M |
Debt Repayment | n/a | -33K | -33K | -38K | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -4.18M | n/a | n/a | n/a | n/a | n/a | n/a | -12K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -39K | 272K | 4.19M | -2.6M | -1.62M | n/a | 962K | 23.43M | 10K | n/a |
Financial Cash Flow | -72K | 239K | -30K | 163.87M | -1.62M | n/a | 962K | 23.43M | 10K | -12K |
Net Cash Flow | -1.93M | -9.63M | -15.65M | 21.63M | -13.95M | -5.3M | -12.38M | 12.19M | -32.71M | -16.12M |
Free Cash Flow | -24.04M | -20.35M | -14.71M | -11.71M | -14.15M | -15.1M | -11.31M | -10.93M | -12.35M | -16.11M |